morphine Sulfate

morphine Sulfate · MORPHINE SULFATE 62.5 mg/mL · Injection, Solution · Bond Pharmacy INC

NDC 81371-1062-01 · 125 mL in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for morphine sulfate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill · avg $28.78 per prescription
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application: —
TE code: —
Approval date: —
Patents / exclusivity: —

Shortage history

In shortage now — Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)Nov 3, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)Nov 3, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)Oct 31, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)Oct 31, 2017
Discontinuation of the manufacture of the drug
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)Oct 31, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)Oct 31, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)Oct 31, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)Oct 31, 2017
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)Oct 31, 2017
Other
month 107 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of morphine Sulfate (Injection, Solution)

Labeler	Strength	First seen	Last seen
Hospira, Inc.	MORPHINE SULFATE 50 mg/mL	Jul 15, 2026	Sep 3, 2026
Bond Pharmacy INC	MORPHINE SULFATE 62.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	MORPHINE SULFATE 4 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	MORPHINE SULFATE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	MORPHINE SULFATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi, USA LLC	MORPHINE SULFATE 4 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi, USA LLC	MORPHINE SULFATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE 25 mg/mL	Jul 15, 2026	Sep 2, 2026
Hikma Pharmaceuticals USA Inc.	MORPHINE SULFATE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MORPHINE SULFATE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MORPHINE SULFATE 1 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MORPHINE SULFATE .5 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MORPHINE SULFATE 4 mg/mL	Jul 15, 2026	Sep 2, 2026
Hospira, Inc.	MORPHINE SULFATE 10 mg/mL	Jul 15, 2026	Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "morphine Sulfate — NDC 81371-1062-01," retrieved September 3, 2026, https://drugdashboards.com/drug/81371106201.

Free to cite with attribution — see how the data is put together.